WithSecure Corporation, Stock Exchange Release, 15 May 2025, at 17:30 EEST Change in the holding of WithSecure Corporation’s own shares WithSecure Corporation has transferred without consideration a total of 52,224 of the company's treasury shares to the recipients of the Restricted Share Plan (RSP) 2022-2024 reward shares. Following the transfer, WithSecure Corporation holds a total of 379,666 of its own shares. Contact information:Laura ViitaVP, Controlling, investor relations and sustainabilityWithSecure ...

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, has been named a Leader in the 2025 Gartner Magic Quadrant for Finance and Accounting (F&A) Business Process Outsourcing (BPO). The Gartner research report evaluated 16 F&A service providers according to a uniform set of criteria, placing companies into four Quadrants: Leaders, Visionaries, Niche Players and Challengers. Gartner defines Leaders as companies that “execute well against their current vision and are wel ...

Serstech’s Chief Financial Officer, Simon Persson, will be on parental leave from June 1 to October 31, 2025. During this period, Michael Sandin will assume the role of interim CFO. Michael Sandin brings over 30 years of experience in finance, including roles as an accountant and as CEO of Outbrave Finance, based in Malmö. Michael has a degree in finance from Lund University in Sweden. “We are pleased to welcome Michael to the Serstech team during Simon’s temporary leave. His extensive experience will ensu ...

The net asset value (NAV) per unit of the Baltic Horizon Fund (the Fund) decreased to EUR 0.6740 at the end of April 2025 (0.6769 as of 31 March 2025). The month-end total net asset value of the Fund was EUR 96.8 million (EUR 97.2 million as of 31 March 2025). A minor NAV decline stemmed from the decrease in fair value of the derivative financial instruments and expenses incurred due to the early partial bond redemption. The EPRA NRV as of 30 April 2025 stood at EUR 0.7200 per unit. In April 2025, the cons ...

MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) today announced its 2025 capital expenditures program, underscoring its commitment to growing capacity, enhancing safety, and powering sustainable growth across its North American network. CN will invest approximately $3.4 billion CAD in capital projects this year, net of customer reimbursements. This year’s capital program includes approximately $2.9 billion allocated to its maintenance and strategic infrastructure initiatives across Cana ...

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.15 per unit for the month of May 2025, representing $1.80 per unit on an annualized basis. The distribution will be payable on June 16, 2025, to unitholders of record as at May 30, 2025. About Allied Allied is a leading owner-operator of distinctive urban workspace in Canada’s major cities. Allied’s mission is to provide knowledge-based organi ...

Group 1 - Saputo will release its fiscal 2025 fourth quarter and full-year financial results on June 5, 2025, with a press release issued after market close [1] - A conference call to discuss the results is scheduled for June 6, 2025, at 8:00 a.m. Eastern Time, featuring Mr. Carl Colizza, President and CEO, and Mr. Maxime Therrien, CFO and Secretary [1] - The webcast presentation will be archived on Saputo's website for those unable to join the live call [3] Group 2 - Saputo is one of the top ten dairy processors globally, producing a wide range of dairy products including cheese, fluid milk, and dairy ingredients [4] - The company is a leading cheese manufacturer in Canada and ranks among the top three cheese producers in the USA, as well as being a top dairy processor in Australia and Argentina [4] - Saputo also produces dairy alternative products and sells its products under market-leading and private label brands in several countries [4]

SHEFFIELD, United Kingdom, May 15, 2025 (GLOBE NEWSWIRE) -- Caro Holdings Inc. (OTC: CAHO), through its subsidiary, has been named agency of record by Value Added Technologies LLC (d/b/a Animoat) to deliver full-service support aimed at increasing sales and expanding the brand's geographic reach. Animoat, an emerging brand in the pet bowl category, has developed the Ani-moat Pet Feeder—a patented, veterinarian-backed product designed to promote cleaner, healthier mealtimes for cats and small dogs. With a mo ...

Core Viewpoint - Aura Biosciences, Inc. has announced a public offering of common stock and warrants, aiming to raise approximately $75 million to support its clinical programs and general corporate purposes [2][3]. Group 1: Offering Details - The public offering consists of 11,735,565 shares of common stock and warrants to purchase 2,933,891 shares of common stock, along with pre-funded warrants for up to 3,571,435 shares at an exercise price of $0.00001 [1]. - The combined offering price for each share of common stock and accompanying warrant is set at $4.90, while the pre-funded warrant and accompanying warrant are priced at $4.89999 [1]. - The offering is expected to close on or about May 16, 2025, subject to customary closing conditions [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to advance clinical programs in early-stage choroidal melanoma, metastases to the choroid, cancers of the ocular surface, and non-muscle invasive bladder cancer [3]. Group 3: Company Overview - Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors, with a mission to transform the lives of patients [7]. - The company's lead candidate, bel-sar (AU-011), is in late-stage development for primary choroidal melanoma and early-stage development for other ocular oncology indications and bladder cancer [7]. Group 4: Management and Underwriters - Leerink Partners and Evercore ISI are acting as joint bookrunning managers for the offering, with LifeSci Capital also serving as a bookrunning manager [4]. - Citizens Capital Markets and Scotiabank are co-managers for the offering [4]. Group 5: Regulatory Information - A shelf registration statement for the offering was filed with the SEC on March 27, 2024, and was declared effective on April 5, 2024 [5]. - A preliminary prospectus supplement was filed with the SEC on May 15, 2025, and will be available on the SEC's website [5].

CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Income Statement Cosmos Health delivered ...